Sign In
Get Clay Free →

Suggestions

    Mike Rogers

    Professor at Garvan Institute of Medical Research

    Professor Mike Rogers is a distinguished researcher at the Garvan Institute of Medical Research in Sydney, Australia. He holds a BSc in Biochemistry (1989) and a PhD in Bone Pharmacology (1994) from the University of Sheffield, UK. His early career included roles at the University of Aberdeen, where he became Professor of Musculoskeletal Pharmacology and led a recognized Centre of Excellence for musculoskeletal research.

    Since relocating to the Garvan Institute in 2012, Professor Rogers has focused on bone biology, particularly the mechanisms of action and side effects of bisphosphonates, drugs widely used for treating osteoporosis and cancer-associated bone diseases. His current research explores the mevalonate pathway's role in immune cell regulation and its implications for autoinflammatory diseases like mevalonate kinase deficiency. He has published extensively, with over 24,000 citations and an h-index of 68. Professor Rogers has also received prestigious awards, including the Herbert A. Fleisch Award (2009) and the Iain T. Boyle Award (2003).123

    Highlights

    Mar 27 · cen.acs.org
    Michael-E-Rogers - C&EN - American Chemical Society
    Michael-E-Rogers - C&EN - American Chemical Society
    Nov 24 · garvan.org.au
    Immunometabolism Lab - Garvan Institute of Medical Research

    Related Questions

    What are Mike Rogers' most significant contributions to bone pharmacology?
    How has Mike Rogers' work impacted the treatment of osteoporosis?
    What is the mevalonate pathway, and how does it relate to Mike Rogers' research?
    Can you explain the importance of Mike Rogers' work on bisphosphonate drugs?
    What are the key findings from Mike Rogers' research on mevalonate kinase deficiency?
    Mike Rogers
    Mike Rogers, photo 1
    Mike Rogers, photo 2
    Add to my network

    Location

    Greater Sydney Area